Shuichi Kaneko
Kanazawa University(JP)Kanazawa University Hospital(JP)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Hepatocellular Carcinoma Treatment and Prognosis, Hepatitis B Virus Studies, Liver physiology and pathology
Most-Cited Works
- → Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma(2020)1,150 cited
- → EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features(2008)1,144 cited
- → Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma(2011)570 cited
- → Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update(2019)526 cited
- → Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion(2016)485 cited
- → SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice(2017)